Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|October 29, 2017
Biomechanics, obesity, and osteoarthritis. The role of adipokines: When the levee breaksVera Francisco, Tamara Pérez, Jesús Pino, et al.
Nature Reviews. Rheumatology|January 6, 2017
Leptin in the interplay of inflammation, metabolism and immune system disordersVanessa Abella, Morena Scotece, Javier Conde, et al.
Journal of Agricultural and Food Chemistry|March 16, 2019
Natural Molecules for Healthy Lifestyles: Oleocanthal from Extra Virgin Olive OilVera Francisco, Clara Ruiz-Fernández, Vicente Lahera, et al.
Journal of Shoulder and Elbow Surgery|August 17, 2018
Early outcomes of locked noncemented stems for the management of proximal humeral fractures: a comparative studyAlberto Jorge-Mora, Samer Amhaz-Escanlar, Sabela Fernández-Pose, et al.
Scientific Reports|November 13, 2015
IL-36α: a novel cytokine involved in the catabolic and inflammatory response in chondrocytesJavier Conde, Morena Scotece, Vanessa Abella, et al.
BMC Health Services Research|January 26, 2019
Management of sexual partners of pregnant women with syphilis in northeastern Brazil - a qualitative studyAna Fátima Braga Rocha, Maria Alix Leite Araújo, Angélica Espinosa Miranda, et al.
Biomedicines|January 21, 2023
Improved Protocol to Study Osteoblast and Adipocyte Differentiation BalanceAna Alonso-Pérez, María Guillán-Fresco, Eloi Franco-Trepat, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2025
Repurposed Drugs for Heterotopic Ossification Management: Revitalizing Therapeutic StrategiesAna Alonso-Pérez, Eloi Franco-Trepat, María Guillán-Fresco, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 15, 2022
Repurposing drugs to inhibit innate immune responses associated with TLR4, IL1, and NLRP3 signaling in joint cellsEloi Franco-Trepat, María Guillán-Fresco, Ana Alonso-Pérez, et al.
British Journal of Pharmacology|October 13, 2021
Amitriptyline blocks innate immune responses mediated by toll-like receptor 4 and IL-1 receptor: Preclinical and clinical evidence in osteoarthritis and goutEloi Franco-Trepat, Ana Alonso-Pérez, María Guillán-Fresco, et al.
Pageof 11